Does the MGIT 960 system improve the turnaround times for growth detection and susceptibility testing of the Mycobacterium tuberculosis complex? [1]

Journal of Clinical Microbiology

Volumn 44, Issue 6, 2006, Pages 2314-2315

  Somoskovi, Akos ^a   Clobridge, Anne ^a   Larsen, Susan C ^a   Sinyavskiy, Oleg ^b   Surucuoglu, Suheyla ^c   Parsons, Linda M ^d   Salfinger, Max ^a  

^a WADSWORTH CENTER   (United States)

^b ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY   (Kazakhstan)

^c CELAL BAYAR UNIVERSITY   (Turkey)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; AUTOMATION; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; DEVICE; LETTER; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SAFETY; TECHNOLOGY;

ANTIBIOTICS, ANTITUBERCULAR; AUTOMATION; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; TIME FACTORS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 33745143602     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00712-06     Document Type: Letter

References (10)

1. Ardito, F., M. Sanguinetti, L. Sechi, B. Posteraro, L. Masucci, G. Fadda, and S. Zanetti. 2000. Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis. New Microbiol. 23:151-158.
2. Goloubeva, V., M. Lecocq, P. Lassowsky, F. Matthys, F. Portaels, and I. Bastian. 2001. Evaluation of Mycobacteria Growth Indicator Tube for direct and indirect drug susceptibility testing of Mycobacterium tuberculosis from respiratory specimens in a Siberian prison hospital. J. Clin. Microbiol. 39:1501-1505.
3. Hale, Y. M., E. P. Desmond, K. C. Jost, Jr., and M. Salfinger. 2000. Access to newer laboratory procedures: a call for action. Int. J. Tuberc. Lung Dis. 4:S171-S175.
4. Kontos, F., M. Maniati, C. Costopoulos, Z. Gitti, S. Nicolaou, E. Petinaki, S. Anagnostou, I. Tselentis, and A. N. Maniatis. 2004. Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. J. Microbiol. Methods 56:291-294.
5. Scarparo, C., P. Ricordi, G. Ruggiero, and P. Piccoli. 2004. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J. Clin. Microbiol. 42:1109-1114.
6. Somoskovi, A., Q. Song, J. Mester, C. Tanner, Y. M. Hale, L. M. Parsons, and M. Salfinger. 2003. Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system. J. Clin. Microbiol. 41:2822-2826.
7. Styrt, B. A., T. M. Shinnick, J. C. Ridderhof, J. T. Crawford, and F. C. Tenover. 1997. Turnaround times for mycobacterial cultures. J. Clin. Microbiol. 35:1041-1042.
8. Takakura, S., S. Tsuchiya, N. Fujihara, T. Kudo, Y. Iinuma, S. Mitarai, S. Ichiyama, K. Yasukawa, and T. Ishiguro. 2005. Isothermal RNA sequence amplification method for rapid antituberculosis drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 43:2489-2491.
9. U.S. Department of Health and Human Services. 2000. Healthy people 2010, 1st ed., vol. I. U.S. Department of Health and Human Services, Washington, D.C.
10. U.S. Department of Health and Human Services. 2000. Healthy people 2010, 1st ed., vol. II. U.S. Department of Health and Human Services, Washington, D.C.